LIFECORE BIOMEDICAL, INC. \DE\·4

Jun 8, 4:37 PM ET

Legion Partners, L.P. I 4

4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Jun 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Lifecore (LFCR) Director Christopher Kiper Receives 25,907 RSUs

What Happened
Christopher S. Kiper, a director of Lifecore Biomedical, Inc. and Managing Director of Legion Partners Asset Management, was granted 25,907 restricted stock units (RSUs) on June 4, 2026. The award is reported as an "A" (award/grant) on the Form 4; no per-share price or cash value is reported (N/A). These RSUs convert 1-for-1 into Lifecore common stock and vest on the earlier of June 4, 2027 or the issuer's 2027 annual meeting (with a minimum ~50-week delay). This is a grant/award (not an open‑market purchase or sale).

Key Details

  • Transaction date: 2026-06-04; Form 4 filed 2026-06-08 (appears timely).
  • Security: Restricted Stock Units (RSUs) that convert 1-for-1 into common stock (footnote F2).
  • Amount granted: 25,907 RSUs; price per share/value: N/A (award).
  • Vesting: Earlier of June 4, 2027 or the 2027 annual meeting of stockholders, subject to the stated timing condition (footnote F3).
  • Previously vested: 58,069 RSUs had already vested as of the filing (footnote F4).
  • Ownership/beneficial interest: The RSUs are held for the benefit of Legion Partners Asset Management; Kiper disclaims personal beneficial ownership except to the extent of any indirect interests through Legion Partners entities (footnotes F4–F9). The Form 4 is filed jointly by multiple Legion Partners entities and reporting persons (footnote F1).
  • Transaction code: A = Award/Grant.

Context
This is a board-service RSU grant rather than a personal open‑market purchase or sale. The award is held for the benefit of Legion Partners Asset Management and, through entity relationships, may be attributed to several Legion Partners reporting persons; Kiper serves on the board as a representative of Legion Partners. Grants to directors are routine compensation for service and do not by themselves indicate a personal trading decision.

Insider Transaction Report

Form 4
Period: 2026-06-04
Kiper Christopher S
Director10% Owner
Transactions
  • Award

    Common Stock

    [F1][F4][F5][F6][F2][F3]
    2026-06-04+25,907103,482 total
Holdings
  • Common Stock

    [F1][F7]
    (indirect: By: Legion Partners, L.P. I)
    4,084,268
  • Common Stock

    [F1][F8]
    (indirect: By: Legion Partners, L.P. II)
    319,286
  • Common Stock

    [F1][F9]
    (indirect: By LLC)
    200
Footnotes (9)
  • [F1]This Form 4 is filed jointly by Legion Partners, L.P. I ("Legion Partners I"), Legion Partners, L.P. II ("Legion Partners II"), Legion Partners, LLC ("General Partner"), Legion Partners Asset Management, LLC ("Legion Partners Asset Management"), Legion Partners Holdings, LLC ("Legion Partners Holdings"), Christopher S. Kiper and Raymond White (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that owns more than 10% of Lifecore Biomedical, Inc.'s (the "Issuer") outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F2]The restricted stock units ("RSUs") convert into Common Stock of the Issuer on a 1 for 1 basis.
  • [F3]Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Issuer first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).
  • [F4]These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.
  • [F5]Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.
  • [F6]The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.
  • [F7]Securities owned directly by Legion Partners I. General Partner is the general partner of Legion Partners I, Legion Partners Asset Management is the investment advisor of Legion Partners I, Legion Partners Holdings is the sole member of Legion Partners Asset Management and managing member of General Partner, and each of Messrs. Kiper and White are managing directors of Legion Partners Asset Management and managing members of Legion Partners Holdings. As a result of these relationships, General Partner, Legion Partners Asset Management, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners I.
  • [F8]Securities owned directly by Legion Partners II. General Partner is the general partner of Legion Partners II, Legion Partners Asset Management is the investment advisor of Legion Partners II, Legion Partners Holdings is the sole member of Legion Partners Asset Management and managing member of General Partner, and each of Messrs. Kiper and White are managing directors of Legion Partners Asset Management and managing members of Legion Partners Holdings. As a result of these relationships, General Partner, Legion Partners Asset Management, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners II.
  • [F9]Securities owned directly by Legion Partners Holdings. As managing members of Legion Partners Holdings, Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Holdings.

Documents

1 file
  • 4
    form409050032_06082026.xmlPrimary

    OWNERSHIP DOCUMENT